Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

ViRexx Medical

ViRexx Medical Corp. is an Edmonton, Alberta based biotechnology company focused on the development of novel therapeutic products for the treatment of cancer and chronic viral infections. ViRexx's most advanced programs include drug candidates for the treatment of ovarian cancer, chronic Hepatitis B & C and solid tumors. The lead product from the AIT™ platform is OvaRex® MAb, a therapy for late-stage ovarian cancer. OvaRex® MAb is currently the subject of a pivotal Phase III clinical trial at more than 60 sites in the United States. ViRexx has licensed to United Therapeutics Corporation (NASDAQ: UTHR), exclusive rights for development and commercialization of OvaRex® MAb and four other monoclonal antibodies worldwide, but ViRexx has retained rights to most member nations of the European Union and certain other countries. ViRexx has established strategic relationships with Dompé Farmaceutici, Medison Pharma, Ltd. and Genesis Pharma S.A. for certain European and Middle-East Countries.


Contact Details:
8223 Roper Road NW
Edmonton
Alberta
T6E 6S4
Canada
Tel:(780) 433-4411
Fax:(780) 436-0068
Email:information@virexx.com
WWW:

www.virexx.com/




Loading...

Press Releases on ViRexx Medical:

BioPortfolio Logo
ViRexx completes $4 million private placement 1st January, 1970 Virexx
ViRexx completes $4 million private placement EDMONTON, Sept. 12 2005 - ViRexx Medical Corp. (TSX: VIR) a company focused on immunotherapy treatments for cancer, chronic hepatitis B & C

BioNews Results for ViRexx Medical:

Paladin Labs sells T-ACTTM platform to IMBiotechnologies
PharmaBiz:  Aug 18 2009 1:58PM Matching: virexx medical

ViRexx Medical Patents:

US Patent No.Title
7390488 Compositions and methods for producing vascular occlusion
6960352 Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent
6887474 Compositions and methods for producing vascular occlusion

ViRexx Medical (REX) Financial information Links from Barchart

REX Quote from from Barchart.com
REX Chart from from Barchart.com
REX Profile from from Barchart.com
REX Opinion from from Barchart.com

View more ViRexx Medical finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 857 times since April 2007, the link to the organisation's website has been followed 173 times

Recent Search Terms used to find this page: Virexx Medical | virexx medical | virexx medical corp | ViRexx Medical | Virex Medical | virexx edmonton | virexx medical | virexx | ViRexx 2009 | ViRexx 2009 | .

Search for more companies in Edmonton

Search for more companies in Alberta



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for ViRexx Medical

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.